Literature DB >> 21609241

The prevalence of age-related macular degeneration in Italy (PAMDI) study: report 1.

Stefano Piermarocchi1, Tatiana Segato, Pasquale Scopa, Morena Masetto, Stela Ceca, Fabiano Cavarzeran, Tunde Peto.   

Abstract

PURPOSE: The present study aimed to estimate prevalence and risk factors associated with age-related macular degeneration (ARMD) in an Italian population and to analyze differences between urban and rural communities.
METHODS: We conducted a population-based cross-sectional study among elderly residents in Northeast Italy. Participants were divided into urban and rural groups based on whether they lived in the city of Padova or the villages of Teolo and Torreglia, respectively. Fundus photographs were graded according to the International Classification for Age-related Maculopathy.
RESULTS: A total of 1162 randomly selected subjects aged 61 years or more were invited to participate in the study. We examined 885 subjects, and 845 were eligible for fundus photograph grading. ARMD was estimated to affect 62.7% of the whole population (drusen 63-124 μm = 48.3%; drusen ≥125 μm = 10.4%; advanced ARMD = 4.1%). Age was confirmed as a risk factor for drusen ≥125 μm and advanced ARMD (Odds Ratio [OR] = 1.47, 95% Confidence Interval [CI] 1.28-1.69 and OR = 1.62, 95% CI 1.28-2.05, respectively, for a 5-year increase in age). The rural group appeared to be at a higher risk of developing large drusen compared to the urban sample (OR = 1.61, 95% CI 1.01-2.63) when adjusting for age and gender.
CONCLUSIONS: The results confirmed that ARMD affects a high percentage of the elderly population in Italy. This study does not support the hypothesis that living in a rural environment or belonging to a population of the Mediterranean basin may be protective against the intermediate stages of the disease.

Entities:  

Mesh:

Year:  2011        PMID: 21609241     DOI: 10.3109/09286586.2011.574334

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  8 in total

1.  Prevalence of age-related macular degeneration in a large European cohort: results from the population-based Gutenberg Health Study.

Authors:  Christina A Korb; Ulrike B Kottler; Christian Wolfram; René Hoehn; Andreas Schulz; Isabella Zwiener; Philipp S Wild; Norbert Pfeiffer; Alireza Mirshahi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-02-25       Impact factor: 3.117

2.  The prevalence and risk factors for age-related macular degeneration in rural-urban India, Sankara Nethralaya Rural-Urban Age-related Macular degeneration study, Report No. 1.

Authors:  R Raman; S S Pal; S Ganesan; L Gella; K Vaitheeswaran; T Sharma
Journal:  Eye (Lond)       Date:  2016-02-26       Impact factor: 3.775

3.  Subretinal drusenoid deposits as a biomarker of age-related macular degeneration progression via reduction of the choroidal vascularity index.

Authors:  Solmaz Abdolrahimzadeh; Mariachiara Di Pippo; Edoardo Sordi; Mattia Cusato; Andrew John Lotery
Journal:  Eye (Lond)       Date:  2022-06-23       Impact factor: 3.775

4.  Polygenic risk score and biochemical/environmental variables predict a low-risk profile of age-related macular degeneration in Sardinia.

Authors:  Rita Serra; Andrea Angius; Vincenzo Rallo; Antonio Pinna; Maristella Steri; Maria Grazia Piras; Michele Marongiu; Florence Coscas; Myriam Gorospe; David Schlessinger; Edoardo Fiorillo; Francesco Cucca
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-10-20       Impact factor: 3.535

5.  Prevalence of age-related macular degeneration in the Republic of Ireland.

Authors:  Kwadwo Owusu Akuffo; John Nolan; Jim Stack; Rachel Moran; Joanne Feeney; Rose Anne Kenny; Tunde Peto; Cara Dooley; Aisling M O'Halloran; Hilary Cronin; Stephen Beatty
Journal:  Br J Ophthalmol       Date:  2015-02-23       Impact factor: 4.638

6.  Morphologic Criteria of Lesion Activity in Neovascular Age-Related Macular Degeneration: A Consensus Article.

Authors:  Stefania Miotto; Nicola Zemella; Elena Gusson; Giacomo Panozzo; Sandro Saviano; Giuseppe Scarpa; Giorgio Boschi; Stefano Piermarocchi
Journal:  J Ocul Pharmacol Ther       Date:  2017-11-17       Impact factor: 2.671

7.  Safety and tolerability of ranibizumab in uni/bilateral neovascular age-related macular degeneration: 12-month TWEYEs study.

Authors:  Francesco Bandello; Giovanni Staurenghi; Federico Ricci; Edoardo Midena; Francesco Viola; Tommaso Lupieri Sinibaldi; Laura Colombo; Elena Peruzzi; Stefania Bassanini
Journal:  Br J Ophthalmol       Date:  2019-05-11       Impact factor: 4.638

8.  Socioeconomic risk factors and age-related macular degeneration in the UK Biobank study.

Authors:  Jennifer Lai Yee Yip; Zaynah Muthy; Tunde Peto; Andrew Lotery; Paul J Foster; Praveen Patel
Journal:  BMJ Open Ophthalmol       Date:  2021-02-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.